Literature DB >> 8440940

Intensity of infection in AIDS-associated cryptosporidiosis.

R W Goodgame1, R M Genta, A C White, C L Chappell.   

Abstract

A fluorescent monoclonal anti-Cryptosporidium antibody was used to count the oocysts in stools of 12 AIDS patients with chronic cryptosporidiosis. Oocyst excretion was present throughout the day in all 12 patients. Stool-to-stool variation in oocyst concentration was within one order of magnitude. Small variations were also found in daily mean oocyst concentration and total daily oocyst excretion in 3 patients who had multiple 24-h stool collections. However, there was a large patient-to-patient variation in mean oocyst concentration (from < 5.0 x 10(3) to 9.2 x 10(5) oocysts/mL) and 24-h total oocyst excretion (from < 6.0 x 10(6) to 1.2 x 10(9) oocysts/day). There was a significant correlation between oocyst excretion and numbers of Cryptosporidium organisms seen on small bowel biopsy. Oocyst excretion was reduced in 4 patients treated with paromomycin, but diarrhea improved only in the 2 patients with high initial oocyst excretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440940     DOI: 10.1093/infdis/167.3.704

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Increased Rates of Respiratory and Diarrheal Illnesses in HIV-Negative Persons Living With HIV-Infected Individuals in a Densely Populated Urban Slum in Kenya.

Authors:  Joshua M Wong; Leonard Cosmas; Dhillon Nyachieo; John M Williamson; Beatrice Olack; George Okoth; Henry Njuguna; Daniel R Feikin; Heather Burke; Joel M Montgomery; Robert F Breiman
Journal:  J Infect Dis       Date:  2015-02-25       Impact factor: 5.226

Review 3.  Cryptosporidiosis in persons with HIV infection.

Authors:  B Ramratnam; T P Flanigan
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

4.  Recovery of waterborne Cryptosporidium parvum oocysts by freshwater benthic clams (Corbicula fluminea).

Authors:  T K Graczyk; R Fayer; M R Cranfield; D B Conn
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

5.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

6.  Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin.

Authors:  D Dionisio; A Orsi; G Sterrantino; M Meli; S Di Lollo; L Ibba Manneschi; M Trotta; M Pozzi; L Sani; F Leoncini
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

7.  High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity.

Authors:  Heuy-Ching Wang; Sara M Dann; Pablo C Okhuysen; Dorothy E Lewis; Cynthia L Chappell; Douglas G Adler; A Clinton White
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

8.  Putative anticryptosporidial agents tested with an immunodeficient mouse model.

Authors:  G J Leitch; Q He
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Gastric involvement in AIDS associated cryptosporidiosis.

Authors:  P Rossi; F Rivasi; M Codeluppi; A Catania; A Tamburrini; E Righi; E Pozio
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; A Janecki; A C White
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.